Hillhouse Capital Management - Q2 2015 holdings

$6.48 Billion is the total value of Hillhouse Capital Management's 32 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 150.0% .

 Value Shares↓ Weighting
QUNR BuyQUNAR CAYMAN IS LTDspns adr cl b$289,069,000
+22.5%
6,746,067
+17.9%
4.46%
+3.6%
YOKU BuyYOUKU TUDOU INCsponsored adr$162,743,000
+108.3%
6,634,430
+6.2%
2.51%
+76.1%
WX NewWUXI PHARMATECH CAYMAN INC$49,743,0001,177,079
+100.0%
0.77%
MR BuyMINDRAY MEDICAL INTL LTDspon adr$32,150,000
+56.2%
1,128,071
+49.9%
0.50%
+31.9%
MMYT NewMAKEMYTRIP LIMITED MAURITIUS$13,029,000662,045
+100.0%
0.20%
CMCM NewCHEETAH MOBILE INCadr$9,365,000326,186
+100.0%
0.14%
NEWR BuyNEW RELIC INC$5,809,000
+79.7%
165,063
+77.1%
0.09%
+52.5%
BZUN NewBAOZUN INCsponsored adr$5,385,000500,000
+100.0%
0.08%
NTES NewNETEASE INCsponsored adr$4,710,00032,510
+100.0%
0.07%
YY NewYY INC$616,0008,855
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONDELEZ INTL INC22Q3 201844.4%
JD COM INC19Q2 201980.2%
SOHU COM INC19Q1 201813.4%
58 COM INC18Q3 20187.8%
TAL EDUCATION GROUP18Q2 20194.4%
CTRIP COM INTL LTD17Q2 201728.4%
BEIGENE LTD14Q2 201925.2%
MELCO RESORT ENTERTAINMENT L14Q3 20186.4%
CAMECO CORP14Q4 20172.2%
ENSTAR GROUP LIMITED12Q2 201921.9%

View Hillhouse Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Hillhouse Capital Management Q2 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
China Jo-Jo Drugstores Holdings, Inc.February 14, 2023403,3344.7%
TScan Therapeutics, Inc.February 14, 2023? ?
Enfusion, Inc.February 14, 20224,975,1837.6%
Enstar Group LTDJuly 19, 2021? ?
Zoom Video Communications, Inc.February 16, 20212,981,2651.5%
NIO Inc.February 14, 2020? ?
Sea LtdFebruary 14, 20204,300,0002.3%
Uxin LtdFebruary 14, 202021,733,0232.6%
Apellis Pharmaceuticals, Inc.February 14, 20192,098,5813.7%
iQIYI, Inc.February 14, 2019240,191,17411.0%

View Hillhouse Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-05
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
42024-02-01
32024-01-25
13F-NT2023-11-14
13F-NT2023-08-14

View Hillhouse Capital Management's complete filings history.

Compare quarters

Export Hillhouse Capital Management's holdings